Get an email when this journal's indexing changes
Added to or removed from Scopus, Web of Science, ABDC, DOAJ, FT50, UT Dallas or ONOS. One confirmation click; unsubscribe anytime.
Nano Today is Scopus-indexed (Q1, CiteScore 18.6), WoS SCIE. It is covered by India's One Nation One Subscription scheme for reading access. Published by Elsevier B.V..
Checked against the index lists dated .
ISSN 1748-0132Verify ISSN ↗1878-044XVerify ISSN ↗
Publisher: Elsevier B.V.
Cost to publish: About US$4,830 to publish open access (publisher list price, via OpenAlex) — subscription publishing may be free
| Subject area | Rank | Pctile | Q |
|---|---|---|---|
| Pharmaceutical Science | 6 / 191 | 97th | Q1 |
| Biotechnology | 14 / 325 | 95th | Q1 |
| Biomedical Engineering | 17 / 342 | 95th | Q1 |
| Materials Science (all) | 25 / 475 | 94th | Q1 |
| Bioengineering | 14 / 168 | 91st | Q1 |
Not listed in: DOAJ, ABDC, ABS / AJG, FT50, UT Dallas, ONOS (APC covered)
Yes — actively indexed in Scopus, coverage 2006–present (also 1970), best quartile Q1, CiteScore 18.6.
Nano Today is Q1 in Pharmaceutical Science (rank 6 of 191), Q1 in Biotechnology (rank 14 of 325) and Q1 in Biomedical Engineering (rank 17 of 342), by CiteScore 2025. It is ranked in 5 subject areas in all.
Nano Today is indexed in the Science Citation Index Expanded, so it may have a Journal Impact Factor in Clarivate's Journal Citation Reports. JCR is paid, so check it for the current value. The closest free measure is its Scopus CiteScore 18.6, which places it in quartile Q1 at the 97th percentile of its subject. Its SCImago Journal Rank (SJR, a free Scopus-based metric) is 2.260, quartile Q1, with an H-index of 202.
The publisher lists an article processing charge of about US$4,830 for open access (source: OpenAlex). Many journals also publish by the subscription route at no cost to the author, so confirm on the journal's own website.
Nano Today is published by Elsevier B.V. Its print ISSN is 1748-0132 and its online ISSN is 1878-044X.
Yes. It is part of the One Nation One Subscription (ONOS) national subscription, so readers at participating Indian institutions get its full text. ONOS does not cover its article processing charge.
Yes — indexed in the Science Citation Index Expanded.
No — it is not registered as an open-access journal in DOAJ or Scopus.
Nano Today has an h-index of 215 and a 2-year mean of 11.15 citations per paper (OpenAlex). Its Scopus CiteScore is 18.6, quartile Q1. On 2-year citations it ranks #3 of 177 Scopus journals in Pharmaceutical Science.
Nano Today published 314 papers in 2025; its busiest recent year was 2024 with 458. 2026* is the year so far.
h-index, i10-index and 2-year mean citedness are open, licence-clear metrics from OpenAlex — not a proprietary impact factor. The subject rank counts only journals that OpenAlex has a figure for; it is not a Scopus or Clarivate ranking. Updated 2026-10-14.
In its latest 90 research articles (2026), authors are most often from China (84.3%), United States (2.6%) and Hong Kong SAR China (1.3%). More than half of recent authorship comes from one country.
Countries are counted fractionally, so a paper by authors from two countries counts half to each.
Scopus status: Active. No retracted papers are recorded. The Problematic Paper Screener flags none of its papers. These are indicators to check, not findings against the journal.
Retractions from OpenAlex; flags from the Problematic Paper Screener (Cabanac, Labbé & Magazinov, CC BY), 2026-09-21 export. A flag marks a paper for a closer look; it is not a finding against the journal.
Index data is curated from public sources (Scopus, Web of Science, ABDC, FT50, UT Dallas, DOAJ). CiteScore and quartiles reflect the latest available Scopus release. Always verify a journal's current status on its official source before submitting.
Comments load as you scroll here.